Human papillomavirus vaccine: safe, effective, underused.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23288945.
- Also identified by DOI 10.3949/ccjm.80a.12084.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vaccination against human papillomavirus (HPV) is safe and effective. It is recommended for females age 9 to 26 and for males age 11 to 26, yet vaccination rates are low. We review the host immune response, the data behind the recommendations for HPV vaccination, and the challenges of implementing the vaccination program.
Medical subject headings
- Papillomavirus Infections
- Papillomavirus Vaccines
- Patient Acceptance of Health Care